Preparation method of temperature and pH sensitive shell cross-linked polymeric micelle
A cross-linked polymer, sensitive technology, applied in the fields of drug combination, liquid delivery, anti-tumor drugs, etc., can solve the problems of strict polymer block ratio requirements, low critical micelle concentration, and uneven micelle size, etc. Achieve excellent drug loading performance, good environmental protection and stability, and easy operation.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0026] The first step of synthesis: Dissolve 3.6g of N-3-aminopropylmethacrylamide hydrochloride monomer in 8ml of deionized water, adjust the pH to 4~5 and freeze it, and dissolve 0.06g of 4-cyano-4 -(Thiobenzoyl)valeric acid and 0.015g 4,4'-azo-(4-cyanovaleric acid) were dissolved in 0.5ml of dioxane solvent, and the two were mixed in a one-necked bottle. The rotor is contained inside, and the glass tee is connected to it, the air is completely excluded, and the solution is placed in a nitrogen-protected environment, and the oil bath is heated to 70°C for 16 hours. Dialyzed in medium for three days, and then freeze-dried to obtain poly(N-3-aminopropylmethacrylamide hydrochloride) polymer.
[0027] The second step of synthesis: Take 0.27g of poly(N-3-aminopropylmethacrylamide hydrochloride) as a macromolecular chain transfer agent and place it in a single-necked bottle containing a rotor, and add 1.5mg of 4,4'- Nitrogen-(4-cyanovaleric acid), 0.7g N-isopropylacrylamide monom...
Embodiment 2
[0032] Same as Example 1, but the amount of 4,4'-azo-(4-cyanovaleric acid) in the first step of synthesis becomes 0.012g of the monomer in the system (N-3-aminopropylmethacrylamide hydrochloride salt) to chain transfer agent (4-cyano-4-(thiobenzoyl)valeric acid) and initiator (4,4'-azo-(4-cyanovaleric acid)) molar ratio is 100:1:0.2.
Embodiment 3
[0034] Same as Example 1, but the water solvent in the first step of synthesis is changed to 15ml, the monomer (N-3-aminopropylmethacrylamide hydrochloride) and the chain transfer agent (4-cyano-4-( Thiobenzoyl)valeric acid) and initiator (4,4'-azo-(4-cyanovaleric acid)) molar ratio is still 100:1:0.25.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com